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Abstract
Background and Purpose: Worldwide unintended pregnancy rates are reported at 40% of all
pregnancies. The United States has an unintended pregnancy rate of 45%. Contraception is safe
and available for most women. Many providers lack evidence-based tools and current
information in assisting clients to choose a highly effective contraceptive method. Intrauterine
devices (IUD) and implants are highly effective contraception. The American College of
Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP)
recommend IUDs and implants as first tier contraception for most sexually active females.
Methods: Implementation of the World Health Organization Decision-Making Tool (WHO
DMT) for contraceptive counseling guidance for clients and providers. The tool consists of a
training manual for providers, exam room posters, flipcharts, and printed patient education
materials. Pre and post intervention surveys were collected and analysis conducted.
Hypothesis 1: The WHO DMT will increase client selection of intrauterine devices as the
preferred contraceptive method. Hypothesis 2: There will be an increased IUD selection by
clients seen by providers using the WHO DMT for counseling. Hypothesis 3: Patients counseled
with WHO DMT will be more satisfied with contraceptive method chosen.
Implications for practice: Use of WHO DMT can impact unintended pregnancy rate by
educating women on the highly effective contraceptive methods, focusing on IUDs, to all
populations, especially the underserved and vulnerable.
Keywords: Contraception, family planning, WHO DMT, intrauterine devices, shared decisionmaking, provider training
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Implementation of the World Health Organization Decision Making Tool to Increase Intrauterine
Device Use
Background and Significance
Family planning is a decision for most sexually active women at some time in their
lifetime. Almost all sexually active, heterosexual women of childbearing age have the potential
for an unintended pregnancy if not using a reliable contraceptive method. On average, women
spend three of their childbearing years attempting pregnancy, being pregnant, or immediate
postpartum; the remaining thirty years of this life stage is spent trying to avoid pregnancy
(Sonfield, Hasstedt, & Gold, 2014). Family planning and contraception is a means to decrease
unintended pregnancies and provide women and men opportunities to plan when, or if, they want
children (Mosher & Abna, 2015). The majority of American families have an average two
children (Finer & Zolna, 2016).
The global unintended pregnancy rate is 40% of all reported pregnancies (Finer & Zolna,
2016). Currently, the unintended pregnancy rate in the United States is 45% of all reported
pregnancies; 27% are reported as mistimed and 18% as unwanted (Finer & Zolna, 2016;
Karpilow & Thomas, 2017; Wyatt et al., 2014). Studies show births resulting from unintended
pregnancies are associated with more adverse maternal and child health outcomes (Sonfield,
Hasstedt, & Gold, 2014; Kavanaugh & Anderson, 2013). Providing women the ability to plan
their families improves health, educational pursuit, and economic opportunities for individuals,
families, and communities (Bader, Kelly, Cheng, & Witt, 2014).
Throughout the ages, women have desired to have control over their fertility and family
size. Popular contraceptive methods have varied through history, ranging from crocodile dung
vaginal inserts to drinking a potentially lethal cocktail of arsenic and mercury, to prevent
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pregnancy (Evans, 2009). Development of and access to modern, safe contraception is
considered one of the greatest public health achievements of the 20th and 21st century (CDC,
1999; Frost & Lindberg, 2013). Family planning and contraception provide women the ability to
choose timing of family, size, and spacing between pregnancies.
Currently, there are eighteen Federal Drug Administration (FDA) approved contraceptive
methods available in the United States, and are considered safe for the majority of women
seeking contraception. Each method has different delivery systems, benefits, risks, indications,
contraindications, user profiles, and effectiveness rates. Many women do not use the most
effective contraceptive method available (Langston, Rosario, & Westoff, 2010). Key factors
contributing to contraceptive failure are incorrect, inconsistent, non-use of contraceptive method,
or ill fit to lifestyle (Dehlendorf, Fitzpatrick, Steinauer, Swaider, Grumbach, Hall, &
Kuppermann, 2017). Clients are more likely to choose a method and continue the method, if
educated, informed, and take part of the contraceptive decision-making process (Dehlendorf,
Kimport, Levy, & Steinauer, 2014).
The Department of Reproductive Health and Research at the World Health Organization,
in partnership with Johns Hopkins Bloomberg School of Public Health, developed a tool known
as the Decision Making Tool (DMT) for Family Planning in 2005 (WHO, 2005). The DMT is
interactive and promotes participation of both provider and client. International experts,
evidence based recommendations, and guidelines laid the foundation for the tool. The DMT
consists of training manuals for providers, exam room posters, flipcharts with client education/
provider prompts, and printable handouts for patient education materials that reinforce
information presented in office. The tool has been used worldwide, but there are no published
studies in the United States. Four studies were conducted using the tool in countries such as
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Mexico, Indonesia, Nicaragua, and Iran (Kim et al., 2005; Kim Davila, Tellez, & Kols, 2007;
Farrokh-Eslamlou, Aghmand, Eslami, & Homer, 2013).
Intrauterine devices (IUDs) are a highly effective method at 99.7% with typical use. The
device is long acting and reversible, with no long-term effect on fertility. Depending on type of
device, the product is active three to ten years and can be removed at any time. The IUDs are
available to most women at no cost through insurance, Title X, and the manufacturer programs.
Purpose Statement
The purpose of this project is three-fold:
1.

Implement and evaluate contraceptive counseling using the WHO DMT

2.

Increase education of options, use, and continuation of chosen contraceptive method,
with emphasis on intrauterine devices

3. Increase satisfaction with contraceptive method
Family planning providers are the gatekeepers to education and contraception. Provider
education about contraception options and use of a tool could increase use of highly effective,
long-acting, reversible contraceptive. Educated clients are more likely to be satisfied and to
continue the chosen method. The importance of this project is to educate women with evidencebased, current information about contraception, to plan their family and to achieve reproductive,
as well as, personal goals.
The capstone project questions are as follows: 1. Does implementation of the WHO DMT
increase IUD use in women desiring contraception? 2. Is there a difference in selection of IUDs
between WHO DMT group compared to non-WHO tool groups? 3. Is there an increase in
patient satisfaction and continuation of the contraceptive method between the study group and
control groups?
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Literature Review
A systematic search of the literature was conducted using search words: contraception,
family planning, unintended pregnancy, long-acting reversible contraception, intrauterine
devices, shared decision-making, counseling tools, World Health Organization Decision-Making
Tool and providers. Search engines included CINAHL, Cochrane Review, EBSCO host
Medline, Pub Med, Psychinfo, and American College of Obstetricians and Gynecologists
Compendium. Initial search used literature dating 2012-2017, but was expanded to include
literature from 2002 and 2018.
Key focus of this literature review was unintended pregnancy, contraception, intrauterine
devices, provider counseling, counseling tools and the WHO DMT.
Unintended Pregnancy
Unintended pregnancy is defined as a pregnancy that is mistimed or unwanted (Finer &
Zolna, 2016). In 2011, there were 6.1 million pregnancies in the United States. Of those
pregnancies, 2.8 million were reported as unintended and 42% ended in termination (Finer &
Zolna, 2016). Data has been collected for the United States since 1981. Data shows an overall
steady decrease in unintended pregnancy in the last three decades, with a significant decrease in
the last ten years (Finer & Zolna, 2016). The unintended pregnancy rate in 2008 was 51% of all
reported pregnancies, with a significant drop reported in 2011 of 45%, a 6% decrease (Finer &
Zolna, 2016; Healthy People, 2010).
Unintended pregnancy places burdens on women, families, society, and the healthcare
system (Dehlendorf, Krajewski, & Borrero, 2014; Finer &Zolna, 2016). Multiple variables (such
as age, socioeconomic status, race, education level, marital, and insurance status) have been
identified as unintended pregnancy risks (Finer & Zolna, 2016; Kavanaugh & Anderson, 2013;
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Mosher, Jones, & Abma, 2015; Sonfield, Hasstedt, & Gold, 2014). Women reporting more
unintended pregnancies are traditionally younger, unmarried, members of a minority group, of
lower socioeconomic status, geographic location either urban or rural, and less educated (Finer &
Zolna, 2016; Frost & Lindberg, 2013; Garbers, Meserve, Kottke, Hatcher, Ventura, & Chiasson,
2012; Kost, Finer & Singh, 2012). Specifically, uninsured women report more unintended
pregnancies, black women more often report being unmarried, and Hispanic women tend to be
younger when becoming pregnant (Kost, Finer, & Singh, 2012). Unplanned pregnancy occurs in
all socioeconomic groups; however, it is more frequent in the most vulnerable populations.
Rates of unplanned pregnancy are two to three more likely in women below the federal poverty
level, while lowest rates are among higher-income, white, married, college graduates (Finer &
Zolna, 2016; Kost, 2015). The rate of unintended pregnancy among the women of higher
socioeconomic status was 18% versus the national rate of 45% (Finer & Zolna, 2016). The
disparities are evident throughout the literature for unintended pregnancy rates, as well as
contraceptive method chosen and successful use of method.
Contraception
Development of and access to modern contraception has been one of the United States
Centers for Disease Control’s greatest public health achievements of the 20th century (CDC,
1999; Frost & Lindberg, 2013). Women in the United States tend to use three different methods
through their reproductive years: condoms in early sexual life, hormonal birth control to space
children, and female sterilization to end childbearing (Mosher, Moreau, & Lantos, 2016).
Research has shown links between contraceptive use to marriage at a later age, attainment of
educational and financial goals, smaller families, longer intervals between children, and family
size. Increasing contraceptive use among women, especially vulnerable populations, is critical to
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reducing unintended pregnancy rates and setting reproductive and personal goals (Marshall,
Nuru-Jeter, Guendelman, Mauldon, Raine-Bennett, 2017).
Presently, there are eighteen FDA approved contraceptive methods widely available in
the United States, which are considered safe for the majority of women seeking contraception.
Each method has a different delivery system, risks, benefits, uses indications and
contraindications, user profiles, and effectiveness rate. Other factors that need to be considered
in choosing contraception include access to health care, insurance coverage, client knowledge,
transportation, partner or family input, and client-provider communication (Dehlendorf,
Grumbach, Schmittdiel, & Steinauer, 2017; Dehlendorf, Levy, Kelley, Grumbach, & Steinauer,
2013). Women do not always use contraception or the most effective method available to them
(Kost, 2015; Mosher, Jones, & Abma, 2015). Research shows women are more likely to choose
and continue a contraceptive method if educated about options, informed about methods, and are
a part of the decision-making process (Dehlendorf, Kimport, Levy, & Steinauer, 2014; Langston,
Rosario, & Westoff, 2010).
Contraceptive method popularity, use, and effectiveness rates have changed over the past
five decades. Oral contraceptives have been available since 1960 and have remained the most
popular hormonal contraceptive in the United States (Kavanaugh, Jerman, & Finer, 2015).
Twenty-six percent of women using contraception choose oral contraceptives. Female
sterilization ranks as the second most popular method at 25%, condoms use at 15%, intrauterine
devices at 10% and male sterilization at 8%. Other options such as the patch, ring, or implant are
used in less than 8% of women seeking contraception (Kavanaugh, Jerman, & Finer, 2015).
Oral contraceptives, patches, vaginal rings, and condoms are referenced in the literature as shortacting reversible contraception and sub-dermal implants and intrauterine devices are known as
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long-acting reversible contraception. The short-acting reversible methods are effective, but are
considered less effective due to user error, inconsistent, incorrect, or non- use (Mosher, Jones, &
Abma, 2015). Inconsistent or incorrect use of contraceptive method accounts for 41% of
unintended pregnancies (Sonfield, Hasstedt, & Gold, 2014).
Four contraceptive methods are considered highly effective contraceptives: female
sterilization, male sterilization, intrauterine devices, and sub dermal implants (ACOG, 2011).
Sterilization has a place in family planning, but is not appropriate for clients under 21 years of
age and women who are unsure of their desire for more children in the future. The long-acting
reversible contraceptives (LARC), IUDs and implants, offer contraceptive effectiveness rate
greater than 99% in preventing pregnancy, equal to or more effective than sterilization. Longacting reversible methods are forgettable and do not require daily, weekly, or monthly user
participation (Hubacher, Spector, Menteith, & Hart, 2017; McNicholas, Madden, Secura, &
Peipert, 2014).
All contraceptive methods, excluding condoms, spermicides, and sponges, require
consultation and prescription from a healthcare provider. Providers have a unique opportunity
for contraceptive counseling and information sharing. Contraceptive choices, indications for use,
and access have increased in the last twenty years, although most women and some providers are
not aware of current methods available to them and use indications (Guida et al., 2014).
Intrauterine Device
Intrauterine Devices (IUDs) are the second most popular contraceptive method in the
world, used by 14.3% of women worldwide, after sterilization (Buhling, Zite, Lotke, & Black,
2014; Joshi, Khadilkar, & Patel, 2015). IUD use varies by continent and region. In Asia, 18% of
women of reproductive age use IUDs and over 40% in China alone (Joshi, Khadilkar, & Patel,
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2015). North America accounts for 1% of total IUD use worldwide (Buhling, Zite, Lotke, &
Black, 2014). IUDs are the most popular of long-acting reversible contraception in the United
States, but continue to lag behind in popularity of oral contraceptives, female sterilization, and
condoms (Mosher, Moreau, & Lantos, 2016).
In the last decade, there has been a significant increase in women choosing a long-acting
reversible contraceptive use, both implants and IUDs. The overall rate has increased from 8.5%
to 11.6% (Mosher, Moreau, & Lantos, 2016). IUDs have become more popular with women of
all ages, have made the most significant contribution in the increase in long-acting reversible
contraception, and have helped to decrease the unintended pregnancy rate (Mosher, Moreau, &
Lantos, 2016). IUD rates increased from 7.7% to 10.3% among women desiring long acting
reversible contraception (Kavanaugh, Jerman, & Finer, 2015; Mosher, Moreau, & Lantos, 2016).
The American College of Obstetricians and Gynecologists (ACOG) stated in 2011 that
long acting reversible contraception, such as IUDs and sub-dermal implants, are the most
effective form of reversible contraception available and are safe for most women seeking
contraception. ACOG (2011) stated that long acting contraception should be considered for all
women desiring long term contraception. Three years later, the American Academy of Pediatrics
recommended long-acting reversible contraception as first-tier contraception for sexually active
adolescents (AAP, 2014). In the past, IUDs were used in women who were married or in a
monogamous relationship, previously given birth, and had been tested and treated, if indicated,
for sexually transmitted infections. Current recommendations have replaced all of the previous
guidelines, and contraindications, making IUDs a first line of contraception most women of
childbearing age (ACOG, 2011; ACOG, 2016).
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There are five IUDs available in the United States, the copper containing non-hormonal
device (Paragard), levonorgestrel containing devices (Mirena and Liletta), and the smaller
versions of Mirena (Skyla and Kyleena). Devices are active from three to ten years, depending
on device, and are forgettable contraception. There is little to no room for user error or device
failure. Few side effects are reported with the hormonal containing devices, with the most
frequent side effect reported as irregular menses or spotting. Bleeding is often self-limiting or
can be managed medically. Clients are more tolerant of the side effects of any method, if
informed and aware of what to expect before starting a contraceptive method (ACOG, 2016;
Mosher, Moreau, & Lantos, 2016).
There have been many barriers of cost, access, and education about long-acting reversible
contraception in the past (Birgisson, Zhao, Secura, Madden, & Peipert, 2015; McNicholas,
Madden, Secura, & Peipert, 2014). Most of these barriers have been removed with changes in
health care coverage and user guidelines (Pace, Dusetzina, & Keating, 2016).
In 2007, a team of researchers at Washington University in St. Louis conducted a prospective
cohort study of women (n=9,256) seeking contraception known. The study is known as
Contraceptive CHOICE Project (McNicholas, Madden, Secura, & Peipert, 2014). Women were
recruited from area family planning clinics and received in-depth counseling. Eligible women
were offered the reversible contraceptive of their choice at no cost for two to three years,
depending upon when they were enrolled. Women choosing IUDs or implants had insertion the
same day. A negative urine pregnancy test was the only prerequisite for IUD or implant
insertion (ACOG, 2011). Contraceptive effect was immediate with device insertion. Use of
back-up for seven days post insertion was recommended as a safeguard. ACOG (2011)
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recommends insertion at any time during the menstrual cycle, post-abortion, immediately after
delivery or after four weeks postpartum.
A standardized counseling script was developed to provide accurate, up-to-date, and
unbiased information on each method. The script described effectiveness, advantages, and
disadvantages of each method. Researchers found women underestimated the effectiveness of
long acting methods and 45% overestimated the effectiveness of oral contraceptives
(McNicholas, Madden, Secura, & Peipert, 2014).
At the beginning of the Washington University study, fewer than 5% of women used LARC
methods. When barriers (such as cost, access, and lack of knowledge) were removed, 75% of the
CHOICE cohort chose a long-acting reversible contraceptive with 46% choosing levonorgestrel
containing IUDs (Mirena, Liletta, Kyleena and Skyla), 12% non-hormonal copper IUD
(Paragard), and 17% subdermal implant (Nexplanon). Long-acting reversible contraceptive
users had a higher continuation rate over short-acting reversible method users at both 12 month
and 24 month follow up (86% vs. 55% at 12 months, 77% vs. 41% at 24 months). The most
common reason for discontinuation of an IUD was irregular bleeding and cramping. There was a
79% decrease in overall pregnancy rate in the CHOICE participants (McNicholas, Madden,
Secura, & Peipert, 2014).
Dehlendorf, Park, Emermni, Comer, Vincett, & Borrero (2014) found that white women are
more likely to use a highly effective contraceptive method (OR 0.65) when compared to black
women (OR 0.49) and Hispanic women (OR 0.57). Women with incomes above 300% of the
federal poverty level were more likely to use contraception, while sterilization was more
prevalent in women at 150% and below the federal poverty level (Kavanaugh, Jerman, & Finer,
2015). Women with less than a college education, two or more children, 35 years of age or
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older, living in a rural area, of a minority group, or report having public or private insurance are
more likely to choose sterilization (Kavanaugh, Jerman, & Finer, 2015). IUD users were women
with a high school education or above, at least one child, 25 to 34 years of age, and living in the
western United States (Kavanaugh, Jerman, & Finer, 2015).
Many factors have changed in the last five years to increase access to IUDs for women. The
Affordable Care Act and health insurance changes have helped women get health care and
contraception at little or no cost. The popularity of long-acting reversible contraception has
increased with clients through print, television advertising, social media, word of mouth, and
information from healthcare providers. The majority of providers offering contraception are
comfortable with the newer devices due to education by manufacturers and the updated
recommendation by ACOG. Rubin, Davis, and McKee (2013) found approximately 18% of
board certified women’s health providers report not feeling comfortable with using or suggesting
the long-acting methods. This could be due to training, education, or previous experiences with
older IUDs. While the unintended pregnancy rate is declining, it is still at 45% in the United
States. Gaps in provider and client education, attention to updates on policies and procedures,
and client access to effective contraception need to be narrowed.
Provider Counseling
Women seek information from a variety of sources including friends, family, partner,
social media, and healthcare providers (Donnelly, Foster, & Thompson, 2014). Not all
information is correct, unbiased, or current. Healthcare providers continue to be the main source
of reliable information, advice, and direction for contraception, and have the most influence in
choice (Dehlendorf et al., 2017; Harper et al., 2013; Johnson, Pion, & Jennings, 2013).
Providers have a responsibility to give women complete, evidence-based, and health literate care
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options. (Harper et al., 2013). Most clients want to participate in health care decisions, but desire
provider input, information, and understanding of the options available to them (Chin-Quee,
Janowitz & Otterness; Dehlendorf et al., 2016; Dehlendorf, Levy, Kelley, Grumbach, &
Steinauer, 2013). Dehlendorf, Grumbach, Schmittidiel, & Steinauer (2017) found women
reporting shared decision-making with their provider were more likely to be satisfied with
contraceptive method, the family planning experience, and continue method. Clients report
being provided information only did not help them reach a decision, but often helped reinforce
what was discussed at the office visit. Providing up-to-date, user friendly, quality, evidencebased resources will improve outcomes, patient satisfaction, and continuation of method
(Dehlendorf, Kimport, Levy, & Steinauer, 2014; Marshall, Nuru-Jeter, Guendelman, Mauldon,
2017).
Family planning differs from other health counseling due the intimate, sensitive, and
personal nature of the subject. Women appreciate a close professional relationship with their
provider based on mutual trust, and respect (Dehlendorf, Grumbach, Schmittdiel and Steinauer
2017; Zolnierek & DiMatteo, 2009). Relationship building increases communication, best fit,
use, and continuation of method (Dehlendorf et al., 2016). Clients are more likely to listen to a
provider with whom they have a relationship and will return to the provider if an issue arises
(Zolnierek & DiMatteo, 2009).
Traditionally, most medical counseling tends to be task focused with providers giving
information and specifics of a treatment plan. Interactions have historically been provider
dominated, with clients having minimum input. Family planning research has demonstrated that
if providers steer clients toward a method, over half of clients report being dissatisfied with both
method and encounter with provider, leading to discontinuation of method (Johnson, Kim, &
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Church, 2014). Client centered counseling improves patient satisfaction and continuation of
method.
Clients and providers come to the appointment with different agendas and backgrounds.
Multiple factors need to be considered for contraceptive choice: lifestyle, personal preference,
partner input, and reproductive and personal goals. Research has shown age, race, ethnicity,
education, income level, marital, and relationship status affect and influence contraceptive choice
and risk for pregnancy (Kost, Finer, & Singh, 2012). A client’s specific counseling needs and
desires should be personalized, complete, accurate, and sensitive to client choice (Donnelly,
Foster, & Thompson, 2014). Barriers (insurance coverage of method, transportation, and
partner preference or opinion) need to be considered for best fit of choice (Donnelly, Foster, &
Thompson, 2014). Relationship building, shared decision-making, anticipatory guidance, and
evidence-based information help increase client use, continuation, and satisfaction (Dehlendorf,
Krajewski, & Borrero, 2014).
Providers come from different backgrounds and specialties; therefore, providers may not
be educated about contraception options and prescribing/use guidelines (Rubin, Davis & McKee,
2013). The American College of Obstetricians and Gynecologists (2011) recommended long
acting reversible contraceptives as a first line contraceptive option for women of all ages, parity,
and appropriate for most medical conditions. Three years later, The American Academy of
Pediatrics recommended intrauterine devices and sub-dermal implants as first line prevention of
pregnancy in sexually active adolescents (AAP, 2014). These recommendations are several
years old, but their use is not reflected in practice settings. Long acting reversible contraceptives
are increasing in use, but are used in less than a quarter of women using contraception (Rubin,
Davis, & McKee, 2013). Providers have multiple tasks during a patient visit. Provider
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education about contraceptive options, as well as access to resources and tools, can help
clinicians counsel clients and provide best care options.
Adequate and evidence-based counseling is the key to providing family planning care and
making every pregnancy wanted and intended. Contraceptive counseling aims to provide clients
basic information to help the client to make an informed choice (Pazol, Zapapta, Tregear,
Maeutone-Smith, & Garvin, 2015). Use of tools can aid clients and guide providers by offering
explanation of qualities, risks, benefits, effectiveness, and contraindications of contraceptive
methods. Research has shown that basic contraceptive counseling tools are more effective for
clients than more complex tools (Steinauer, Trussell, Mehta, Condon, Subramaniam, & Bourne,
2006).
WHO DMT
In 2005, the World Health Organization and Johns Hopkins Bloomberg School of Public
Health developed a family planning tool known as the Decision Making Tool for Family
Planning. The tool’s goal is to improve the quality of family planning counseling through
information and guidance for clients and providers (WHO, 2005). The tool was developed for
generic use and to be adapted for differences in language, culture, education level, populations,
and available resources. The tool’s design allows for use by professionals and laypersons trained
in family planning through structured workshops and training manuals. Client education
materials include exam room posters, flipcharts, and client education handouts. All materials are
available through the World Health Organization and are no cost. The materials have been
translated in 14 languages, written for limited health literacy, with simple diagrams and
illustrations to aid in client education and understanding (WHO, 2005).
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Several studies have used the Decision-Making Tool, but there is no published research
using the tool in the United States. Kim, Kols, Martin, Silva, Rinehart, Prammawat, Johnson and
Church (2005) used the WHO DMT in Mexico for contraceptive counseling. Thirteen providers
participated and were videotaped while counseling family planning clients, three months before
implementation of the tool and one month after implementation. Pre-intervention clients (n=38)
were compared to post-intervention clients (n=45). After each consultation, a field researcher
conducted an exit interview to collect demographic data and social history. The researchers
found that providers using the tool gave clients more information, that the communication
increased between provider and client, and that clients had increased understanding. The use of
the flipchart improved accuracy of information and prompted providers to tailor information
specific to the client. Clients sought more clarification, asked more questions, and expressed
desire for a contraceptive method more often. The researchers analyzed decision-making,
information given, eye contact, and usability and acceptability of the tool. The tool was found to
improve the amount of information given, patient involvement, and support for informed
decision-making.
Kim, Davila, Tellez, & Kols (2007) used the tool in Nicaragua to investigate impact on
family planning communication. Fifty- nine providers were videotaped while counseling clients.
A survey was given to pre-intervention clients (n=210) and post-intervention (n=216) to
evaluate client contraceptive choices at one of 49 government health clinics. The results showed
providers increased efforts to identify and meet client needs, especially new family planning
clients, increased effort to involve clients, and provided more thorough client screening and
education. Clients reported having improved understanding to make an informed decision for
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contraceptive choice. The tool had more impact on less educated and new clients. Providers
reported the flipchart a helpful to aid in client education.
Farrokh-Eslamlou, Aghlmand, Eslami, & Homer (2013) used the DMT in Iran to
improve family planning processes and outcomes. The tool was implemented in 52 public health
clinics in four areas of Iran. A pre- and post-intervention survey was conducted with providers
(n=78), pre-intervention clients (n=448), and post-intervention clients (n=547). Data was
collected by face-to-face observation, client-provider interaction, and exit interviews. The
findings showed clients in the post-implementation group participated more actively in
contraceptive selection. Providers gave clients more information and tailored to the individual.
Increased provider-client communication (both verbal and nonverbal) positively impacted client
choice of more effective methods, and increased the quality of the information provided to the
client. Client satisfaction with family planning services increased from 72% to 99%.
A pilot study was conducted in Indonesia (2004) using the Decision Making Tool. The
results of the study have not been published to date. Currently, a research team from the
University of Pennsylvania is implementing the tool in Botswana. The study started three years
ago; however, due to political and cultural challenges, has just recently started enrolling study
participants.
Most family planning researchers develop their own education and outcome
measurements tools. Differences in populations and cultures make having a universal tool and
measurement difficult, if not, impossible. There was no standardized evaluation tool for the
WHO DMT. The investigator contacted the WHO, Johns Hopkins Bloomberg School of Public
Health, and researchers at the University of Pennsylvania, currently conducting a study using the
WHO DMT in Botswana; no one knew of an outcome or evaluation tool.
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Theoretical Framework
Ajzen’s Theory of Planned Behavior (TPB, Appendix 1) provided guidance for this
project.

The Theory of Planned Behavior suggests that behavior is determined by intentions

and/or attitudes (beliefs about a behavior or action), subjective norms (beliefs about other’s
attitudes toward a behavior), and perceived control (belief about one’s own ability to perform the
behavior). These three constructs make-up the theory (Ajzen, 2005). Individuals can make
logical and reasoned decisions about a specific behavior by evaluating information available or
presented to them.
The first construct is intention or attitude toward behavior. The individual has to decide
if the behavior is either favorable or unfavorable, and that decision will lead to the consequences
of the desired behavior change. In both the study and control groups, attitude and intention
played a prominent role in the contraceptive decision. Some of the factors of influence were
religious beliefs, age, relationship status, desire for children in the future, previous pregnancies,
number of children, and desire for contraception.
The second construct, subjective norms include: social norms, social pressure, and
outside influences on the client. Input from a parent, peer, or partner either assisted or deterred
the client to choose a contraceptive method. For older teen (16-20 years old) participants, peer
and partner played a large role. In younger teens, parents had more of a voice in contraceptive
decision. Married or women who were cohabiting, were more likely to have partner input.
Perceived control and the perception of ease or difficulty of a task is the final construct.
The more favorable the attitude and intention, support of social norms, and when the client
perceives control, the more likely the intention to perform behavior.
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Attitude of the client and the provider are both important for success. Both parties have
personal beliefs, perceptions or attitude about contraceptive methods, outside influences, and
goals. Social norms and perceptions carry a lot of weight and opinions or expectations from
partner, family, friends, and healthcare providers can shape decisions. The performance of a
behavior is determined by individual intention, influences of significant others, and the
perception of control. The research shows a strong correlation between perceived control,
behaviors, and follow through. (Ajzen, 2005).
Methods and Procedures
Sample
The pilot study was a randomized convenience sample between December 1, 2017 and March
1, 2018. The target population included females of childbearing age (12-50 years), desiring
contraception, new or established clients, English or Spanish speaking, and consent to participate
in the study. Exclusion criteria were females under 12 years or over 50 years of age,
permanently sterilized, currently seeking a pregnancy, or declined study participation.
The study sample included an intervention group, and two control groups, each with 30
participants, totaling 90 subjects. The subjects in each group saw a different provider, all
providers are board certified Women’s Health nurse practitioners.
Group 1, the intervention group, used the WHO DMT for education and information on
contraceptive methods. The provider for Group 1 performs all aspects of obstetric and
gynecological care, including IUD and implant placement and removal. Group 2 was a control
group using non-WHO materials for contraceptive education. The provider for Group 2 provides
all aspects of care, including IUD and implant placement and removal. Group 3 was a second
control group using non-WHO materials. The provider provides all aspects of care, except
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procedures including IUD and implant placements or removals. Group 3 clients desiring a
device are referred to the providers who perform procedures.
Setting
The project setting is an urban federally qualified community health center in the southeast
United States. The health center provides primary and preventative services including primary
care, pediatrics, women’s health, and dental. The women’s health area is composed of six exam
rooms, three per provider. The three exam rooms used by the investigator were the only rooms
with the WHO DMT materials.
The organization has eight different clinical sites around the city and provide care for
homeless, refugee, and other vulnerable populations. The clinic serves all clients, without
regard to the ability to pay, making healthcare accessible to all people. Fees are assessed by a
sliding scale based on the federal poverty level guidelines. All nationalities, socioeconomic
levels, insurance status, religions, sexual orientations, ages and languages are represented in the
client base.
In 2016, women’s health generated 6351 individual visit encounters, 2769 or 43.5% were
family planning related. During that period, over 500 prescriptions were written for oral
contraceptives and less than 200 clients were identified as IUD users.
Intervention
Most family planning researchers design their own data collection and measurement tools
due to the unique properties and differences in populations. A pre-intervention retrospective
chart review was conducted beginning December 1, 2017 and continued until March 1, 2018 to
collect demographic data, sample characteristics, past and present contraception history, and
facilitate assignment to provider group (Appendix 2).
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The ORTHO Birth Control Satisfaction Assessment Tool was used to collect data at
follow- up to assess patient satisfaction with contraceptive method. The ORTHO Assessment
Tool was developed in 2004 for assessment of patient satisfaction with hormonal contraceptive
methods: oral contraceptives, Depo-Provera, patches, and vaginal rings (Colwell, LoCoco,
Karvois, Mathias, Cimms, & Friedman, 2004). The investigator contacted Dr. A. J. Friedman to
obtain a copy of the tool, permission to use, and permission to adapt the tool for IUD use
(Appendix 3). Only the last four questions were used due to being applicable to IUD use and
client satisfaction. Data was collected from subjects choosing IUDs at a four week post-insertion
follow up office visit for device placement and to address any problems. Clients choosing other
contraceptives were contacted by phone call or office visit.
All subjects (N=90) were identified by chart number with no names or personal
identifiers. Subjects were placed in group according to the provider seen, each group had 30
participants and data was filed accordingly. All paper copies of surveys and WHO DMT
materials were in a locked file. Electronic data was entered into Statistical Package for the
Social Sciences 25 (IBM, 2017) accessed by investigator only. All data is password protected on
a secure server.
The implementation of the WHO tool began December 1, 2017. Exam rooms and
materials were prepared with posters, flipchart, and printed material after clinic hours on
November 30, 2017. Posters were placed on the wall near the exam table for clients to read
while waiting for the provider. Patient charts were reviewed the day before office visit for
collection of demographic data and preparation for visit.
Clients were asked about study participation and consent was obtained. Participants in
the study group (Group 1) were seen in one of the exam rooms with the WHO DMT materials.
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The WHO DMT group was provided with tangible, consistent information that was reinforced in
three different ways; poster, flipchart, and printed education materials. During the first visit, the
investigator asked a detailed sexual and contraceptive history, desire for continued contraception,
preferred method, and future reproductive plan. The flipchart was used for client education to
guide the discussion. The flipchart provided reminders to the provider for counseling clients.
Printed take home materials were given to client matching the flipchart and poster.
If a client chose an IUD, a prescription was sent to the pharmacy and insertion was done
at a follow up visit one to two weeks from decision to placement. At the return visit for
insertion, clients were encouraged to ask any questions or concerns before device insertion. The
two comparison groups (Group 2 and 3) used non-WHO materials for contraceptive education
and clients were provided contraceptive method of choice. Each comparison group had equal
numbers at the beginning of the study. The loss to follow-up was 14 subjects out of 90
participants or 15.5%. Two attempts by phone call were made to contact clients.
Instrument
The ORTHO Birth Control Satisfaction Assessment Tool (ORTHO BC-SAT) was used
to guide questions on patient satisfaction after choosing a contraceptive method. The ORTHO
BC-SAT consists of 13 questions for eight identified domains: Ease of use, Compliance,
Lifestyle impact, Symptom/Side effect bother, Menstrual impact, Future fertility concerns,
Assurance/Confidence, and Overall satisfaction (Colwell, Mathias, Cimms, Rothman, Friedman,
& Patrick, 2006). All questions contributed information to the study, but only questions 10-13
directly related to satisfaction and were the only ones used. Each question is scored with a five
to seven point Likert scale. The Likert scale items were categorized into dichotomous variables
with 0= (1,2,3) “not satisfied” and 1=(4, 5, 6, 7) “satisfied”.
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Evaluation Plan
Statistical analysis was completed under the guidance of Gwen Rinker, PhD. Data was
analyzed with Statistical Package for the Social Sciences (Version 25 IBM, 2017). Statistical
significance was defined a priori as α=.05, two tailed. Comparisons of categorical data was
analyzed using Chi-square for study questions one, two, and three. Continuous data was
analyzed using paired t-tests for study question one.
Results
Demographics
Demographic and sample characteristics of Group 1 participants (n=30) and the
comparison groups participants in Group 2 (n=30) and Group 3(n=30), were analyzed using Chisquare for categorical variables and independent t-test for continuous variables. There were no
statistically significant differences between the groups (Table 1). Comparisons of past and
present contraceptive method of each group is listed in Table 2.
Question 1. Did the Implementation of the World Health Organization Decision Making
Tool for Family Planning to increase selection of intrauterine devices?
Total number of intrauterine devices was compared between the number of women
selecting IUDs before and after the intervention in both the study and control groups. A paired ttest was conducted to evaluate the impact of the WHO DMT on IUD selection/uptake (Table 3).
There was a statistically significant increase in IUD use in the study group from Time 1
(M=1.07, SD=.254) to Time 2 (M=1.63, SD=.49), t (-5.461), p=<.001 (two-tailed). The mean
increase in IUD use was -.567 with a 95% confidence interval ranging from -.779 to-.354. The
eta squared statistic (.51) indicated a large effect size. The use of the WHO DMT had a
statistically significant increase in IUD selection before and after the intervention.
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Chi-square for independence was conducted to compare association between present
IUD selection and information/tool use. Results show χ2=4.887 (1, n=90), p=.027, phi=.254.
There was a significant association between present IUD selection and information/tool used for
contraceptive education (Table 4). The findings indicate the WHO DMT information made a
small to moderate difference with IUD selection.
Ten women had further questions after reading take home materials; all ten clients
returned for device placement. Three of these women had chose oral contraceptives at initial
office visit, but contacted the clinic to change methods. All three clients had the device placed
and reported being satisfied at the four week post-insertion visit.
Question 2. Did provider make a difference in choice of contraception- focusing on
intrauterine devices?
A Chi-square test for independence was conducted to compare association between the
different provider groups and number of IUDs selected. The Chi-square indicated a significant
association, χ2= 31.02 (2, n=90), p=<.001, phi=.587. These findings indicate a large effect
(Table 5). The subjects in Group 1 selected IUDs more than either control group.
A Chi square test for independence was conducted to compare association between the
two control groups and number of IUDs selected. The Chi-square indicated no significant
association between control groups, χ2= .414 (1, n=90), p=.520.
Results show a difference in provider between the study group and the control groups,
but no difference between the two control groups.
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Question 3. Did client satisfaction increase with contraceptive method use of the World
Health Organization Decision Making Tool?
Chi-square tests for independence was conducted to compare association between the
study group and several factors (happiness with contraceptive method, plan for continuation of
method, recommendation to others, and overall satisfaction). There were no significant
associations between client satisfaction and group membership (Table 6).
A Chi-square for independence was performed for individual provider seen and overall
satisfaction with contraception and was found to have a significant association, χ2=14.52 (2,
n=90), p=<.001, phi=.437. The findings indicate that the provider a client sees can make a
moderate difference in overall satisfaction with contraceptive method.

Ethical Considerations
The Internal Review Board from Bellarmine University approved the research study in
November 2017 (Appendix 4). The health center approved the study in May 2017 (Appendix 5).
Participation was voluntary and offered to all women meeting inclusion criteria. Subjects were
asked for consent to participate and informed they could drop out at any time. Clients were
provided with information on all methods of contraception, a copy of consent to participate in
study, and the phone numbers to the committee chairperson, Dr. Ta’Neka Lindsay, and to the
Bellarmine IRB (Appendix 6).
Coercion is a concern in family planning and contraception counseling. Clients have a
choice of any contraceptive method they choose. Providers are not to judge, persuade, or
withhold method a client chooses. For institutions receiving federal funds for family planning
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(Title X), all contraceptive methods must be available at request. Failure to provide
contraceptive methods can lead to loss of funding and/or fines.
Family planning has a set of regulations very different from the rest of medicine. Any
client requesting contraception, regardless of age, can get services without parental consent.
Parents or partners cannot force a method on a client. The choice of contraception is up to the
individual. Providers often educate parents as well as clients about methods and their uses, risks,
benefits, and alternatives.
Barriers
The main barrier was time with clients. Appointment and scheduling allows for 15 minute visits throughout the clinic, walk-in or scheduled clients. Presenting the tool and
counseling took an average of 12 minutes. Women seeking contraception for the first time took
up to 30 minutes to educate on options and uses. Most women are eager to learn about
contraception and family planning, but the materials worked best when tailored to individual
client’s desires and individual needs, and not the same for all women. Time management is
essential for the WHO DMT to be of use and efficient. Printed materials readily available can
help prepare for the office visit. During the study period, materials were not printed prior to visit
due to communal office setting and to insure handouts were for Group 1 participants only. Upon
completion of the study, materials will be pre-printed and available to any interested party.
Eventually, video teaching will be available for exam room education using portable tablets and
on a television monitor in the waiting room. Interpreters will record videos in Spanish. Due to
lack of interpreter for all languages, only printed material will be available for some languages.
A few providers may not be open to new methods of teaching clients. This could be a
barrier if the tool is adopted organization wide. During the study period, providers showed
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interest in the materials and to implementation into their practice. All education information and
representatives at the World Health Organization will be shared with anyone interested.
The pharmacy has been a barrier in the past. Before and during the study period, the
investigator has worked closely with the pharmacy to ease workload for this project. A new
process was initiated between pharmacy, nursing staff, and the provider. The director of
pharmacy has been open to meeting, changing the process, and working with the investigator to
improve the system.
Discussion
The most significant finding was the provider /study group and the information used when
counseling clients made a difference on the outcome of increased IUD selection. Using the WHO
DMT in clinical practice provided an opportunity to facilitate client-centered, consistent, current,
and non-directive communication between the client and provider to make a choice about
contraception. The tool was enthusiastically received by clients and the results show a trend
toward more long-acting reversible contraceptive use, especially IUDs. Several clients had no
previous knowledge of any of the long-acting reversible contraceptive methods, and if they did,
they were not aware the methods were available to them.
The WHO DMT eliminated some of the provider bias. The tool is non-directive towards
a specific method and presents all methods to the client, so she has access to information on all
methods and can make the choice she is more likely to continue to use and able to achieve her
reproductive goals. In the study group, women with a personal or reproductive plan or goal such
as: joining the army, going to college, applying for graduate school, had fear of being deported
or moving to another city, chose more long acting methods. Clients often stated that the IUD or
implant gave them one less thing to worry about while settling into a new place or experience.
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Group 1clients commented often about liking the poster in the room and the take home
material that matched what was presented.

Individual providers use a variety for client

education, which can vary greatly and be confusing to clients. Many of the pamphlets currently
used are provided by pharmaceutical manufacturers and promote one method or another. Clients
that see more than one provider may get confusing or conflicting information. The WHO DMT
provides consistency.
Some of the weaknesses of the project include: provider resistance to change, bias about
IUDs, and the time restraints with the WHO DMT. Some providers may not be interested in
performing IUD or implant insertions, or some may have a bias or personal belief that does not
support IUD use. Clients can always see a provider who does these procedures at the current or
different clinical site. Time management is critical for successful use of the tool. Preparation of
handouts and exam rooms before the client visit can decrease time educating the client. When
the tablets and waiting room television for client education is complete, clients can be learning
about contraception before the provider comes in for the visit.
Future studies need to be for longer a timeframe and follow clients at least two years.
The investigator plans to follow the participants in Group 1 for 12 months, and Groups 2 and 3
assessed at annual exams. The long-acting reversible contraceptives became more popular and
available in the last decade. Many women did not know about contraceptive options and opted
for sterilization, bilateral tubal ligation continues to be the second most popular method of
contraception.

A future qualitative study to interview sterilized women and identify if

sterilization would have been their choice, if long-acting reversible contraception had be
available or discussed before the procedure.
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Implication for Practice
Over a decade ago, international leaders in the field of family planning were consulted to
develop a tool for educating clients about contraceptive options. The WHO DMT was developed
in 2005 and continues to be used worldwide today. Use in the United States has not been evident
in the literature. The United States continues to have an unintended pregnancy rate of 45%; the
highest rate of a developed country. Multiple, effective contraceptive options are available to
women at little or no cost. The gap appears to be education of both providers and clients about
available contraceptive options and tools to aid in education.
The WHO DMT is available to all providers. The investigator will share information
with the organization at the monthly provider staff meeting, which includes providers from all
eight clinical sites within the organization. Presenting information of project findings could
potentially increase the number of providers who offer family planning, training for internists
and pediatricians could expand the target population and reach more women at risk for an
unintended pregnancy. The investigator would like to present the study and the WHO DMT to
the Louisville Metro Health and Wellness Program and the state family planning director for
implementation to other facilities in the city and state. The tool could aid and educate providers
and clients throughout the state, especially high- risk populations; rural areas, homeless women,
refugees, and clients with limited health care access.
The current state of health care seems more uncertain than in the past decade. Insurance
coverage and laws governing healthcare can change suddenly. Providing evidence-based, best
practice guidelines, and effective options is one way to help clients be able to make the best
choice for themselves and their families, present and plan for the future.
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Appendix 2
To be obtained through chart and intake information by researcher
Demographic Data:
1. Age
2. Race
3. Ethnicity
4. Insurance Status
5. Employment Status
6. Education
7. Religious Preference
8. Sexual Orientation
9. Number of Pregnancies
10. Number of Live Births/Abortions-induced or spontaneous
11. Desire for children in future
12. Past Family Planning
13. Partner/Friend/ Family Input
14. Frequency of Intercourse
15. Medical Conditions
16. Relationship Status
17. New or Established Patient
18. Federal Poverty Level
19. Method Selected
20. Provider Seen
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Appendix 3

ORTHO Birth Control Satisfaction Assessment Tool (Ortho BC-SAT)
In this section, we will be asking you questions about your current method of birth control.
Please circle the one number for each answer that best describes you.
1. Birth Control is prescribed to be used on a specific schedule. How convenient or
inconvenient is it for you to take your birth control exactly as directed?
a. Extremely convenient
b. Very convenient
c. Somewhat convenient
d. Neither convenient or inconvenient
e. Somewhat inconvenient
f. Very inconvenient
g. Extremely inconvenient
2. How easy or difficult is it for you to use your birth control exactly as directed (swallowing
a pill, applying a patch, checking IUD strings, getting an injection)?
a. Extremely easy
b. Very easy
c. Somewhat easy
d. Neither easy or difficult
e. Somewhat difficult
f. Very difficult
g. Extremely difficult
3. How often do you forget to use or check your birth control exactly as directed?
a. None of the time
b. A little of the time
c. Some of the time
d. Most of the time
e. All of the time
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4. How worried are you that you won’t be able to get pregnant in the future, when you stop
birth control?
a. Not worried at all
b. Somewhat worried
c. Very worried
d. Extremely worried
5. Have you been bothered by any side effects of birth control?
a. Breast tenderness
b. Feeling moody
c. Feeling irritated
d. Acne
e. Cramping
f. Irregular periods or spotting
g. Headaches
h. Bloating
i. Nausea
j. Weight gain
k. Hair loss or thinning
6. Some women have a period every month, while others experience it less often due to the
method of birth control. How happy are you with the frequency of your period?
a. Extremely pleased
b. Very pleased
c. Somewhat pleased
d. Neither pleased or displeased
e. Somewhat displeased
f. Very displeased
g. Extremely displeased
7. Does your birth control help with these things? Circle all that apply.
a. Reduce menstrual pain
b. Lighten flow of your period
c. Reduce the number of days of your period
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8. Do you have any side effects with your birth control?
a. Yes
b. Unsure
c. No
9. Do the side effects interfere with your daily life?
a. Yes
b. Unsure
c. No
10. Does your birth control interfere with your sex life?
a. Yes
b. Unsure
c. No
11. My sex life has become more spontaneous with my current birth control method.
a. Yes
b. Unsure
c. No
d. Not sexually active
12. I am happy with my birth control method.
a. Yes
b. Unsure
c. No
13. The advantages of my birth control outweigh the disadvantages.
a. Yes
b. Unsure
c. No
14. I have easily incorporated my birth control into my way of life and routine.
a. Yes
b. Unsure
c. No
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15. My birth control interferes with my ability to participate in other activities Ex. Sports
a. Yes
b. Unsure
c. No
16. My birth control is only known by those I choose to tell or show.
a. Yes
b. No
17. I trust my body is receiving the right amount of hormone from my birth ontrol.
a. Yes
b. Unsure
c. No
18. I feel confident I am using the right birth control method for me.
a. Yes
b. Unsure
c. No
19. I feel confident that my birth control is right for my partner(s) and me.
a. Yes
b. Unsure
c. No
20. I am confident and pleased with my birth control method.
a. Yes
b. Unsure
c. No
21. I feel secure that my birth control is working.
a. Yes
b. Unsure
c. No
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22. Would you recommend your current birth control to a friend or family member?
a. Yes, definitely
b. Yes, probably
c. I am unsure
d. No, probably not
e. No, definitely not
23. How willing are you to continue your birth control?
a. Extremely willing
b. Very willing
c. Somewhat willing
d. Not at all
e. No longer need birth control
24. Compared to other birth control methods you have used in the past, would you say…
a. I am much more satisfied with my current method of birth control
b. I am somewhat more satisfied on my current birth control method
c. I am neither more satisfied or less satisfied
d. I am somewhat dissatisfied with my current method of birth control
e. I am much more dissatisfied with my current method of birth control
25. Overall, how satisfied are you with your birth control method?
a. Extremely satisfied
b. Very satisfied
c. Somewhat satisfied
d. Neither satisfied or dissatisfied
e. Somewhat dissatisfied
f. Extremely dissatisfied
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26. How helpful was your provider in helping choose a birth control method?
a. Extremely helpful
b. Very helpful
c. Somewhat helpful
d. Neither helpful or unhelpful
e. Somewhat unhelpful
f. Extremely unhelpful
27. Did you find the information provided on birth control methods helpful?
a. Extremely helpful
b. Very helpful
c. Somewhat helpful
d. Neither helpful or unhelpful
e. Somewhat unhelpful
f. Extremely unhelpful
28. Did you find the clinic helpful in providing you the birth control method of your choice?
a. Yes, I got it that day
b. Yes, but I had to come back
c. Not sure what I want
d. No, the clinic did not provide what I wanted
e. No, I did not want a birth control method
29. Would you come back to the clinic or recommend the clinic to others?
a. Yes, definitely
b. Probably
c. No

Thank you for your participation in this survey. If you have any questions, please contact
Kim Anna at kanna@fhclou.org or 502-774-8631 ext.8594
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Appendix 4 IRB Approval
Institutional Review Board (IRB) received the submitted proposal, “Implementation of the
World Health Organization Decision Making Tool for Increased IUD Use” and designated it
#621. Approval was granted on November 21, 2017 after an expedited review and was approved
under the category of “Collection of data through non-invasive means. The review period
extends to November 21, 2018. The committee chair was notified by email from Frank
Hutchins, Chair of the Bellarmine Institutional Review Board.
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Appendix 5

Consent to Participate in Research Study of World Health Organization
Decision Making Tool for Family Planning
Introduction:
You are invited to participate in a research study. The study is using a tool and education
materials to teach women about family planning and birth control methods. The World Health
Organization developed information and a way to present it. The study is to see if the tool helps
with family planning decisions.
This study is being done by Kim Anna at Family Health Center at Portland location. Bellarmine
University School of Nursing is the sponsor. Dr. Ta’Neka Lindsay is the committee professor
overseeing the study.
The study will completed at the clinic during the time of the visit. A follow-up visit or phone
call will be made in 4-12 weeks. There will be other people invited into the study. The study
will take about 15 minutes to participate at a visit and follow up appointment or call.
Purpose and Background:
New techniques and tools are made in the health field every day. At Family Health Center, we
are always looking at ways to best serve you. The tool being tested could be a help in teaching
women about birth control and family planning options. A trial of the tool is needed to see if
clients like it or it helps make decisions. Our best resources to find this information is our
clients.
Procedures:
Clients will give consent or decline participation. The tool to be tested has three parts- an exam
room poster, a flipchart, and handouts to take home. The entire teaching time is usually an
average of 10-15 minutes in other studies using the tool. The tool will be used at the visit, while
you are here. A follow up survey will be done at a later date. The researcher will gather
information and comments from you. At any time, you can decide not to participate. You do not
have to answer any particular question that makes you uncomfortable or which may render you
prosecutable by law. All answers will be anonymous and confidential.
Risks/ Benefits:
If questions are too sensitive, they may produce discomfort.
There are no other foreseeable risks.
The data collected in this study may not benefit you directly. However, the information learned
in this research may be helpful to others in the future.
Confidentiality:
Absolute confidentiality cannot be guaranteed. All data will be held in confidence to the extent
permitted by law. If the data is published, the subject’s identity will not be revealed. All
information will be gathered and kept in a secure, private and locked file cabinet- only accessible
by researcher.
Voluntary Participation:
Participation is voluntary. Clients may refuse or withdraw at any time without any penalty or
losing any benefits to which you are entitled.
Rights as a Research Subject:
If you have any questions about your rights as a research subject, you may call the Institutional
Review Board at Bellarmine at 502-272-7963. You will be given the opportunity to discuss any
question about your rights as a research subject, in confidence with a member of the Board. This
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is an independent committee composed of members of the University community and lay
members of the community not connected with this institution. The Board has reviewed this
study. Kim Anna is the primary investigator and can be reached at 502-774-8631 ext. 8594 or at
kanna@fhclou.org
Acknowledgement of Consent and Signatures:
Clients acknowledge giving consent and returning the completed survey, subject acknowledges
participation.
Potential Conflict of Interest:
The researcher is part of a program of study and is not being compensated for the study or your
participation. The researcher is studying the tool and outcomes and will be not direct or
persuade clients into a family planning method- the survey is for information only.
Family Health Center, Bellarmine University, nor the individual researcher will not directly
benefit from the study. The study will add to the knowledge about teaching methods and may
give better ways and tools to teach and provide better care.

X_________________________________________
Client

Date___________________

X_________________________________________
Investigator

Date___________________
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Appendix 7
SWOT Analysis

Strengths

Weaknesses

Comprehensive, proven counseling

Time consuming

International use

Requires provider training on tool

User friendly

Patient resistance

Unbiased

May not be accepted at organization

Opportunities

Threats

Better counseling = Better Outcomes

Not widely used in US

Increase of highly effective contraception

Resistance- providers and clients

Decreased unintended pregnancy rates
Increase use in US
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Appendix 8
Budget
DNP Donated Hours

$10,000

Program and Tools

$0

Other Staff

$400

Office Supplies

$700

Statistician

$300

SPSS 24 subscription

$85

Office Space

$0

Total

$11,485

52

IMPLEMENTATION OF THE WORLD HEALTH ORGANIZATION

53

Appendix 9
Gantt Chart
Task
Identify DNP Committee chairman
• Dr. Ta’Neka Lindsay
Select DNP Project Members
• Dr. Kathy Hager
• Dr. Joy Monsma
Meet with Committee Members Discuss Proposal
Revision of Proposal
Obtain Approval for Project
IRB Approval Bellarmine University
IRB Approval Family Health Center
Retrospective Chart Review
Educate staff WHO DMT
Implement Data Collection Questionnaire (12/1-3/1)
Follow Up Data Collection
Update Committee Members
Analyze Data with Statistician
Finalize Draft to DNP Committee
Present Findings with Staff at FHC
Final DNP Presentation

Summer 16
Complete
7/16

Fall 16

Semester Timeline
Spring 17 Summer 17
Fall 17

Spring 18

Complete 2/17
Met individually
Pending
Pending
Pending
Complete 5/17
Pending
Pending
Pending
Pending
Ongoing
Pending
Pending
Pending
Pending

Summer 18
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Appendix 10
Stakeholders/Key Personnel
Providers
Nursing
Medical Assistants
Scheduling/Front Desk
Billing/Accounting
Administration
Health Educators
Pharmacy staff
Clients
Insurers
Taxpayers
Community
Society as a whole
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Table 1
Demographics Characteristics of Sample
Variable

Group1
Study Group

Group2
Control A

Group3
Control B

Total
Population

Age in years/SD
Range 12-50

28 (8.66)
16-48 yrs

27.9 (7.27)
15-41 yrs

31.8 (7.70)
19-45 yrs

29.16 yrs(SD
8.03)

Race
Caucasian
Black
Other

10 (33%)
13 (43%)
7 (23%)

11 (37%)
13 (43%)
6 (20%)

12 (40%)
12 (40%)
6 (20%)

33 (37%)
38 (42%)
19 (21%)

Income Median
Range 0-95,000

10,937
0-95,000

14,970
0-91,000

8688
0-83,000

11,531
0-95,000

Insurance
None
Public
Private

8 (27%)
18 (60%)
4(13%)

5 (17%)
18 (60%)
7 (23%)

4 (13%)
21 (70%)
5 (17%)

17 (19%)
57 (63%)
16 (18%)

Percent Poverty/Median
Range 0-450%

53%*FPL
0-450%

73%*FPL
0-450%

42%* FPL
0-404%

56% *FPL

Menarche
Range 9-16

12.5 yrs
10-16 yrs

12.07 yrs
9-15 yrs

12.43 yrs
10-16 yrs

12.33 (SD 1.36)

Relationship
Single
Cohabitate
Married

7 (23%))
12 (40%)
11 (37%)

9 (30%)
12 (40%)
9 (30%)

7 (23%)
14 (47%)
9 (30%)

23 (26%)
38 (42%)
29 (32%)

Age of first sex
Range 12-25 yrs

15
12-24 yrs

17
13-25 yrs

14
12-25 yrs

15.6 yrs
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Frequency of sex
Daily
Weekly
Monthly
Less than monthly
Number of Pregnancies
None
One
Two
Three
Four or more

56

1 (3%)
18 (60%)
5 (17%)
6 (20%)

1 (3%)
17 (57%)
1 (3 %)
11 (37%)

2 (7%)
23 (77%)
4 (13%)
1 (3%)

4 (5%)
58 (64%)
10 (11%)
18 (20%)

5 (17%)
6(20%)
7 (23%)
7 (23%)
5 (17%)

13 (43%)
3 (10%)
1 (3%)
7 (23%)
6 (20%)

10 (33%)
5 (17%)
6 (20%)
4 (13%)
5 (17%)

28
14
14
18
16

7 (23%)
1 (10%)
5 (17%)
7 (23%)
1 (3%)

14 (47%)
2 (7%)
5 (17%)
5 (17%)
4 (13%)

12 (40%)
4 (13%)
9 (30%)
3 (10%)
2 (7%)

33
7
19
15
7

Religion
None
Christian
Catholic
Muslim
Other

13 (43%)
8 (27%)
7 (23%)
2 (7%)
0 (0%)

19 (63%)
3 (10%)
5 (17%)
2 (7%)
1 (3%)

20 (67%)
5 (17%)
4 (13%)
1 (3%)
0 (0%)

52 (58%)
16 (18%)
16 (18%)
5 (6%)
1 (1%)

Education
Less than HS
HS grad
Some college
College grad
More than college

6 (20%)
17 (57%)
2 (7% )
4 (13%)
1 (3%)

4 (13%)
21 (70%)
1 (3%)
3 (10%)
1 (3%)

1 (3%)
24 (80%)
3 (10%)
2 (7%)
0 (0%)

11 (12%)
62 (69%)
6 (7%)
9 (10%)
2 (2%)

Transportation
Own car
Public
Walk or friend

20 (67%)
5 (17%)
5 (17%)

23 (77%)
4 (13%)
3 (10%)

22 (73%)
6 (20%)
2 (7%)

65 (72%)
15 (17%)
10 (11%)

Patient Status
New
Established

2 (7%)
28 (93%)

3 (10%)
27 (90%)

4 (13%)
26 (87%)

9 (10%)
81 (90%)

Number of Children
None
One
Two
Three
Four or more

*FPL- Federal Poverty Level
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Table 2
Contraceptive Methods Comparison between Groups Pre and Post Intervention

Group
Group 1
Study

BCM

Pills
Depo Provera
Condoms
Vaginal Ring
IUD
Implant
Total
Group 2 Pills
Control A Depo Provera
Condoms
Patch
IUD
Implant
Total
Group 3 Pills
Control B Depo Provera
Condoms
Patch
IUD
Implant
Total

Past
Past
Present
Present
Frequency Percent Frequency Percent
13
43.3
2
6.7
4
13.3
1
3.3
6
20.0
1
3.3
1
3.3
1
3.3
2
6.7
19
63.3
4
13.3
6
20.0
30
100.0
30
100.0
8
26.7
8
26.7
8
26.7
13
43.3
11
36.7
5
16.7
1
3.3
1
3.3
1
3.3
2
6.7
1
3.3
1
3.3
30
100.0
30
100.0
17
56.7
17
56.7
2
6.7
4
13.3
6
20.0
4
13.3
1
3.3
2
6.7
3
10.0
2
6.7
1
3.3
1
3.3
30
100.0
30
100.0
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Table 3
Hypothesis 1: The WHO DMT will increase IUD use.
Dependent variable- IUD use
Independent variable- WHO DMT
Comparison of IUD Use Rates Before and After Implementation of WHO DMT

Groups
N=90

Previous IUD
M (SD)

Group 1/Study
(n=30)
Group 2/Control
(n=30)
Group 3/Control
(n=30)

Present IUD
M (SD)

t- value

1.07 (.254)

1.63 (. 490)

-.5.461(29)

.000

1.00 (.000)

1.07 ( .254)

-1.439(29)

.161

1.10 (.305)

1.10 ( .305)

.000(29)

Paired t-test
Confidence Interval 95%

Table 4
WHO DMT/IUD
Variable
Tool/IUD

Significance
p-value

𝜒2
4.887

Chi-square for independence

df
1

p-value
.027

phi
.254

1.000
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Table 5
Hypothesis 2: There will be a difference in IUD use between providers groups using the WHO
DMT.
Dependent variable- IUD use
Independent variable- provider group
Variable
Provider/IUD
IUD/Control

𝜒2
31.023
4.14

Chi-Square for Independence

df
2
1

p-value
p =<.001
p =.520

Phi
.587
-.126
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Table 6
Hypothesis 3: There is a difference in patient satisfaction with birth control method between the
group/WHO DMT use.
Dependent variable- Patient satisfaction
Independent variable- Group/WHO DMT
Client Satisfaction
Variable
Happy with
BCM
Advantages
/Disadvantages
Recommend to
others
Continue
method
Information
Helpful
Provider
Helpful
Overall
Satisfaction

Χ2
.155

df
1

p-value
.694

phi
-.045

.760

1

.383

.10

.262

1

.609

-.162

.458

1

.499

.078

33.4

1

.000

.609

9.972

1

.002

.362

19.484

1

.002

.465

Chi-Square for Independence

